Delineation of immunoreactive, conserved regions in the external glycoprotein of the human immunodeficiency virus type 1.
about
Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine designA novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12.Structural dynamics of HIV-1 envelope Gp120 outer domain with V3 loop.Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.Isolate-specific differences in the conformational dynamics and antigenicity of HIV-1 gp120.Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein.Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160.Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies.Resistance to neutralization by broadly reactive antibodies to the human immunodeficiency virus type 1 gp120 glycoprotein conferred by a gp41 amino acid change.Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120.Immunological evidence for interactions between the first, second, and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1.Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humansA recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure
P2860
Q24679395-E6C34E96-74F0-4154-B757-703D72CBC863Q31143293-5D22C616-E91B-41B0-94DE-36A9EBFCFF2BQ34280044-6DEBC9E1-2EDA-4A9A-A04E-E2D2732017F3Q34359035-FD267FD8-A403-4F74-9A8F-E811B5A09ECBQ34885869-ADF54641-E9F4-4BF1-BFC9-B4BA0D8351DBQ35857331-7B1BCA3D-C2F7-427E-8274-CC3C0BD435B7Q35886254-95063EF8-46DF-4BDF-8ABA-7CD649F428AFQ36620408-7A0B001A-38AC-4123-80E5-6229AA2E6A2CQ36626451-7A22E8F3-70AA-4CEF-BA46-E49FAE17BCD6Q36635175-ABA873B1-91A2-429A-9DF4-A8FDE1B93FB4Q36636717-8C616E3F-3E1C-4195-A041-D336214D3920Q36641374-8A4D79CB-AB60-4D30-82C9-4BC7743D2F2AQ39588870-7F932503-113D-4A16-9EAD-FD2C3DD8C37A
P2860
Delineation of immunoreactive, conserved regions in the external glycoprotein of the human immunodeficiency virus type 1.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Delineation of immunoreactive, ...... immunodeficiency virus type 1.
@ast
Delineation of immunoreactive, ...... immunodeficiency virus type 1.
@en
type
label
Delineation of immunoreactive, ...... immunodeficiency virus type 1.
@ast
Delineation of immunoreactive, ...... immunodeficiency virus type 1.
@en
prefLabel
Delineation of immunoreactive, ...... immunodeficiency virus type 1.
@ast
Delineation of immunoreactive, ...... immunodeficiency virus type 1.
@en
P2093
P356
P1476
Delineation of immunoreactive, ...... immunodeficiency virus type 1.
@en
P2093
Kalyanaraman VS
Sarngadharan MG
di Marzo Veronese F
P304
P356
10.1089/AID.1992.8.1125
P50
P577
1992-06-01T00:00:00Z